<DOC>
	<DOCNO>NCT02422888</DOCNO>
	<brief_summary>The current trial compare protective effect ticagrelor prasugrel microvascular dysfunction patient revascularized ST elevation myocardial infarction .</brief_summary>
	<brief_title>Reducing Micro Vascular Dysfunction Acute Myocardial Infarction Ticagrelor</brief_title>
	<detailed_description>Coronary microvascular dysfunction highly prevalent revascularized ST-elevation myocardial infarction important prognostic implication . Current data suggest ticagrelor might superior prasugrel reduction coronary microvasculature dysfunction . Thus , design clinical trial compare microvascular function revascularized ST-elevation myocardial infarction patient treatment steady state ticagrelor prasugrel . Coronary microvascular dysfunction assess index microcirculatory resistance primary percutaneous coronary intervention 1 month follow-up infarct-related vessel non-infarct related vessel .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Provision inform consent 2 . Patients present STelevation myocardial infarction &lt; 12 hour symptom onset 3 . Successful percutaneous coronary intervention infarctrelated vessel modern drugeluting stent 4 . Intermediate stenosis noninfarctrelated vessel ( 5090 % ) 1. history myocardial infarction 2 . Participation another clinical study investigational product precede 30 day 3. history cerebrovascular accident ( CVA ) 'transient ischaemic attack ' ( TIA ) 4 . History intracranial haemorrhage 5. indication use oral anticoagulant therapy ( i.e . acenocoumarol ) 6. severe liver dysfunction ( ChildPugh score 1015 ) 7. congestive heart failure 8. cardiogenic shock 9. leave ventricular ejection fraction &lt; 35 % 10. bleeding diathesis 11. age â‰¥ 75 &lt; 18 12. body weight &lt; 60 kg 13. gout 14. coagulation disorder 15. severe pulmonary disease 16. pregnancy breast feed 17. limited life expectancy 18. platelet count &lt; 100 000/mm3 19. history drug addiction alcohol abuse past 2 year 20. need chronic nonsteroidal antiinflammatory drug 21. creatinine clearance &lt; 30 mL/min dialysis 22. chronic total occlusion ( CTO ) 23 . Left main disease 24. allergy contraindication ticagrelor prasugrel 25 . Contraindication adenosine 26 . Patients unable follow onsite 27 . Unable undergo contraindication MRI 28 . Contraindication drugeluting stent 29 . Inability obtain informed consent 30 . Coronary artery bypass graft medical history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ST elevation myocardial infarction</keyword>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Ticagrelor</keyword>
	<keyword>Prasugrel</keyword>
</DOC>